Research by Joel Cantor et al. “Access to Hepatitis C Treatment during and after Incarceration in New Jersey, United States: A Qualitative Study”

April 17, 2023

Abstract

Despite effective antiviral therapy for hepatitis C virus (HCV), people who are incarcerated and those returning to the community face challenges in obtaining HCV treatment. We aimed to explore facilitators and barriers to HCV treatment during and after incarceration. From July–November 2020 and June–July 2021, we conducted 27 semi-structured interviews with residents who were formerly incarcerated in jail or prison. The interviews were audio-recorded and professionally transcribed. We used descriptive statistics to characterize the study sample and analyzed qualitative data thematically using an iterative process. Participants included five women and 22 men who self-identified as White (n = 14), Latinx (n = 8), and Black (n = 5). During incarceration, a key facilitator was having sufficient time to complete HCV treatment, and the corresponding barrier was delaying treatment initiation. After incarceration, a key facilitator was connecting with reentry programs (e.g., halfway house or rehabilitation program) that coordinated the treatment logistics and provided support with culturally sensitive staff. Barriers included a lack of insurance coverage and higher-ranking priorities (e.g., managing more immediate reentry challenges such as other comorbidities, employment, housing, and legal issues), low perceived risk of harm related to HCV, and active substance use. Incarceration and reentry pose distinct facilitators and challenges to accessing HCV treatment. These findings signal the need for interventions to improve engagement in HCV care both during and after incarceration to assist in closing the gap of untreated people living with HCV.

Keywords: HCV; Hepatitis C; treatment; direct-acting antiviral DAA; prison; jail; incarceration; linkage to care; qualitative

Citation

Kamat, Samir, Sankeerth Kondapalli, Shumayl Syed, Gabrielle Price, George Danias, Ksenia Gorbenko, Joel Cantor, Pamela Valera, Aakash K. Shah, and Matthew J. Akiyama. 2023. “Access to Hepatitis C Treatment during and after Incarceration in New Jersey, United States: A Qualitative Study” Life 13, no. 4: 1033. https://doi.org/10.3390/life13041033

Recent Posts

NJ Postsecondary Employment and Earnings Dashboard Now Available

The New Jersey Statewide Data System is pleased to release its updated Postsecondary Employment and Earnings Dashboard. This dashboard uses linked, longitudinal administrative data from the Office of the Secretary of Higher Education and the New Jersey Department of...

Rutgers MHA ranked #26 in 2026 by U.S. News and World Report

The Rutgers Master of Health Administration program (MHA) program has been ranked #26 in the nation in the 2026 U.S. News & World Report rankings, climbing two spots from last year and continuing a steady rise from #32 in 2024 and #28 in 2025. “We are incredibly...

Chen et al. Use Google Street View to Verify Cannabis Retailers

Evaluating the Use of Google Street View to Visually Verify the Locations of Cannabis Retailers in the United States Extracted from Websites, 2015–2018 Abstract Our ability to advance public health and policy responses to cannabis legalization is limited by a lack of...

“Work Trends RU” Podcast with Steve Reynolds

Steve Reynolds of Independent Colleges and Universities of New Jersey Guests on Work Trends RU Podcast In the latest episode of Work Trends RU, host Dr. Carl Van Horn speaks with Steve Reynolds, president and CEO of Independent Colleges and Universities of New...